highdose – Health

FDA Approves Wegovy, a High-Dose Version of the Diabetes Drug Semaglutide for Use as Aid to Weight Loss

Wegovy — a high-dose version of the diabetes drug semaglutide — has been approved as a new aid to weight loss by the U.S. Food and Drug Administration. Studies funded by drug maker Novo Nordisk showed that participants who received weekly injections of the drug had an average weight loss of 15% and lost weight… Read More »

2nd time’s the charm? Novo Nordisk reups bid for high-dose Ozempic after March FDA snub

Novo Nordisk is back for round two with a new Ozempic dosing regimen. The diabetes specialist resubmitted to the FDA on Friday after a March snub, renewing its bid to compete with Eli Lilly’s already approved higher dose. Novo’s resubmission aims to nab an approval for a once-weekly, 2-mg dose for Ozempic, a GLP-1 drug already approved for weekly dosing at… Read More »